Development of nano- and microscale chondroitin sulfate particles for controlled growth factor delivery.

Size scale plays an important role in the release properties and cellular presentation of drug delivery vehicles. Because negatively charged chondroitin sulfate (CS) is capable of electrostatically sequestering positively charged growth factors, CS-derived nanoscale micelles and microscale spheroids were synthesized as potential growth factor carriers to enhance differentiation of stem cells. Particles were characterized for morphology, size distribution, surface charge and cytocompatibility, as well as release of transforming growth factor-β1 (TGF-β1) and tumor necrosis factor-α (TNF-α). CS micelles were spherical and negatively charged with a bimodal distribution of 324.1±8.5 and 73.2±4.4 nm diameters, and CS microspheres possessed a rounded morphology and a diameter of 4.3±0.93 μm. Positively charged TGF-β1 demonstrated minimal release after loading in CS microspheres, while negatively charged TNF-α exhibited substantial release over the first 15 h, suggesting that TGF-β1 electrostatically complexed with CS. The micelles and microparticles were found to be cytocompatible at moderate concentrations with marrow stromal cell monolayers and within embryonic stem cell embryoid bodies. These synthesis techniques, which allow the formation of CS-based carriers over a variety of nano- and microscale sizes, offer versatility for tailored release of positively charged growth factors and controlled CS presentation for a variety of stem cell-based applications in tissue engineering and regenerative medicine.

[1]  P. Maurel,et al.  Differential regulation of expression of hyaluronan-binding proteoglycans in developing brain: aggrecan, versican, neurocan, and brevican. , 1998, Biochemical and biophysical research communications.

[2]  A. Hoffman.  Hydrogels for Biomedical Applications , 2001, Advanced drug delivery reviews.

[3]  L. Díaz de León,et al.  Differential effects of transforming growth factors beta 1, beta 2, beta 3 and beta 5 on chondrogenesis in mouse limb bud mesenchymal cells. , 1997, The International journal of developmental biology.

[4]  Peter W Zandstra,et al.  Incorporation of biomaterials in multicellular aggregates modulates pluripotent stem cell differentiation. , 2011, Biomaterials.

[5]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[6]  Shyni Varghese,et al.  Chondroitin sulfate based niches for chondrogenic differentiation of mesenchymal stem cells. , 2008, Matrix biology : journal of the International Society for Matrix Biology.

[7]  M. Yamagata,et al.  A large chondroitin sulfate proteoglycan (PG-M) synthesized before chondrogenesis in the limb bud of chick embryo. , 1986, The Journal of biological chemistry.

[8]  S. Provencher.  A constrained regularization method for inverting data represented by linear algebraic or integral equations , 1982 .

[9]  K. Xia,et al.  In vitro chondrogenesis of human bone marrow-derived mesenchymal progenitor cells in monolayer culture: activation by transfection with TGF-beta2. , 2003, Tissue & cell.

[10]  Xinhua Lin,et al.  Functions of heparan sulfate proteoglycans in cell signaling during development , 2004, Development.

[11]  J. S. Park,et al.  Chondrogenic differentiation of mesenchymal stem cells embedded in a scaffold by long-term release of TGF-beta 3 complexed with chondroitin sulfate. , 2009, Journal of biomedical materials research. Part A.

[12]  Jenn‐Shing Chen,et al.  Controlled immobilization of chondroitin sulfate in polyacrylic acid networks , 2007, Journal of biomaterials science. Polymer edition.

[13]  Eun Seong Lee,et al.  Protein complexed with chondroitin sulfate in poly(lactide-co-glycolide) microspheres. , 2007, Biomaterials.

[14]  M. Höök,et al.  Glycosaminoglycans and their binding to biological macromolecules. , 1978, Annual review of biochemistry.

[15]  Liangliang Huang,et al.  Preparation and properties of chitosan chondroitin sulfate complex microcapsules. , 2008, Colloids and surfaces. B, Biointerfaces.

[16]  Antonios G Mikos,et al.  In vitro release of transforming growth factor-beta 1 from gelatin microparticles encapsulated in biodegradable, injectable oligo(poly(ethylene glycol) fumarate) hydrogels. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[17]  Andrés J. García,et al.  Inhibition of in vitro chondrogenesis in RGD-modified three-dimensional alginate gels. , 2007, Biomaterials.

[18]  Yu‐Der Lee,et al.  Preparation of amphiphilic poly(L-lactide)-graft-chondroitin sulfate copolymer self-aggregates and its aggregation behavior. , 2006, Biomacromolecules.

[19]  J. Bathon,et al.  Gelatin/chondroitin 6-sulfate microspheres for the delivery of therapeutic proteins to the joint. , 1998, Arthritis and rheumatism.

[20]  D. L. Weeks,et al.  TGFbeta2 and TGFbeta3 have separate and sequential activities during epithelial-mesenchymal cell transformation in the embryonic heart. , 1999, Developmental biology.

[21]  Thomson Ja.  Embryonic stem cell lines derived from human blastocysts (vol 282, pg 1147, 1998) , 1998 .

[22]  J. Siepmann,et al.  How porosity and size affect the drug release mechanisms from PLGA-based microparticles. , 2006, International journal of pharmaceutics.

[23]  P. Zandstra,et al.  Reproducible, Ultra High-Throughput Formation of Multicellular Organization from Single Cell Suspension-Derived Human Embryonic Stem Cell Aggregates , 2008, PloS one.

[24]  S A Newman,et al.  Role of transforming growth factor-beta in chondrogenic pattern formation in the embryonic limb: stimulation of mesenchymal condensation and fibronectin gene expression by exogenenous TGF-beta and evidence for endogenous TGF-beta-like activity. , 1991, Developmental biology.

[25]  Y. M. Lee,et al.  Controlled release of platelet-derived growth factor-BB from chondroitin sulfate-chitosan sponge for guided bone regeneration. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[26]  Hans P Merkle,et al.  Microencapsulation by solvent extraction/evaporation: reviewing the state of the art of microsphere preparation process technology. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[27]  J. Hui,et al.  Cartilaginous ECM component-modification of the micro-bead culture system for chondrogenic differentiation of mesenchymal stem cells. , 2007, Biomaterials.

[28]  M. Miyasaka,et al.  Binding of a Large Chondroitin Sulfate/Dermatan Sulfate Proteoglycan, Versican, to L-selectin, P-selectin, and CD44* , 2000, The Journal of Biological Chemistry.

[29]  Y. Ikada,et al.  Controlled release of growth factors based on biodegradation of gelatin hydrogel , 2001, Journal of biomaterials science. Polymer edition.

[30]  Ross A. Marklein,et al.  Homogeneous and organized differentiation within embryoid bodies induced by microsphere-mediated delivery of small molecules. , 2009, Biomaterials.

[31]  T. McDevitt,et al.  Rotary Suspension Culture Enhances the Efficiency, Yield, and Homogeneity of Embryoid Body Differentiation , 2007, Stem cells.

[32]  W. Zauner,et al.  In vitro uptake of polystyrene microspheres: effect of particle size, cell line and cell density. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[33]  Daniel S Kohane,et al.  Microparticles and nanoparticles for drug delivery. , 2007, Biotechnology and bioengineering.

[34]  Sven Frokjaer,et al.  Loading into and electro-stimulated release of peptides and proteins from chondroitin 4-sulphate hydrogels. , 2002, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[35]  P. Brandtzaeg,et al.  Brief Definitive Report the Complex Pattern of Cytokines in Serum from Patients with Meningococcal Septic Shock Association between Interleukin 6, Interleukin 1, and Fatal Outcome , 2022 .

[36]  D. Ornitz,et al.  Heparan and chondroitin sulfate on growth plate perlecan mediate binding and delivery of FGF-2 to FGF receptors. , 2007, Matrix biology : journal of the International Society for Matrix Biology.

[37]  Jussi Taipale,et al.  Growth factors in the extracellular matrix , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[38]  Stuart A. Newman,et al.  Role of transforming growth factor-β in chondrogenic pattern formation in the embryonic limb: Stimulation of mesenchymal condensation and fibronectin gene expression by exogenenous TGF-β and evidence for endogenous TGF-β-like activity , 1991 .

[39]  P. Schmid,et al.  Differential expression of TGF beta 1, beta 2 and beta 3 genes during mouse embryogenesis. , 1991, Development.

[40]  J. Thomson,et al.  Embryonic stem cell lines derived from human blastocysts. , 1998, Science.

[41]  Kristi S. Anseth,et al.  Synthesis and Characterization of Photopolymerized Multifunctional Hydrogels: Water-Soluble Poly(Vinyl Alcohol) and Chondroitin Sulfate Macromers for Chondrocyte Encapsulation , 2004 .

[42]  Yu‐Der Lee,et al.  Synthesis and characterizations of amphiphilic poly(L-lactide)-grafted chondroitin sulfate copolymer and its application as drug carrier. , 2007, Biomolecular engineering.

[43]  D. Goeddel,et al.  Human tumor necrosis factor. Production, purification, and characterization. , 1985, The Journal of biological chemistry.

[44]  Jayanth Panyam,et al.  Polymer degradation and in vitro release of a model protein from poly(D,L-lactide-co-glycolide) nano- and microparticles. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[45]  Jeffrey A Hubbell,et al.  Photopolymerized hyaluronic acid-based hydrogels and interpenetrating networks. , 2003, Biomaterials.